Screening for Familial Hypercholesterolaemia
Dr. Kees Hovingh (AMC Amsterdam, The Netherlands)
Recorded at the first PACE Lipid Master Class, held in Amsterdam, The Netherlands on May 22-23, 2015
Dr. Kees Hovingh discusses recent insights into the actual prevalence of homozygous and heterozygous FH, how FH patients can best be identified, and how they should be managed.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: